Callan JMB Inc. (CJMB) company profile
Close on Nov 17, 2026Market cap $2.07MP/E –Yield –
About Callan JMB
Services-Business Services, NEC, SIC 7389
Callan JMB Inc. provides temperature-controlled logistics, fulfillment, and monitoring services primarily for the life sciences sector. The company specializes in cold chain solutions for temperature-sensitive items such as biological materials, vaccines, and cell therapies. Its primary offerings include emergency preparedness and rapid response deployment, specialized reusable thermal packaging, fulfillment services, and proprietary predictive tracking technologies, including Sentry monitoring and Ship2Q inventory software. Callan JMB serves life sciences organizations, commercial healthcare clients, and public sector entities, including government agencies, the United Nations, and NATO.
The enterprise operates across major parts of the United States and Canada, maintaining a dispatch-capable service center infrastructure and licensing in multiple jurisdictions. It also holds an entity in Pune, India, with no active operations. Corporate headquarters are situated in Spring Branch, Texas.
Summary of the business section of Callan JMB's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Callan JMB Inc.
- Founded
- 2024
- Headquarters
- Spring Branch, TX
- Address
- 244 Flightline Drive 78070
- Phone
- (830) 438-0395
- Website
- callanjmb.com
- Employees
- 20, Dec 31, 2025
- Industry
- Services-Business Services, NEC
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Rosenberg Rich Baker Berman, P.A., Somerset, New Jersey
Stock & identifiers
- Ticker
- CJMB
- Exchange
- Nasdaq
- IPO date
- Feb 6, 2025
- Shares outstanding
- 6M, Aug 12, 2026
- Public float
- $7.40M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2032545
- CUSIP
- 131100109
- ISIN
- US1311001093
- FIGI
- BBG01QK922X6
- Share class FIGI
- BBG01QK923R1
- EIN
- 99-0931141
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Wayne D. Williams | CEO, Chairman and President, Director | 2,377,468 |
| Eric L. Kash | Executive Vice President, Director | – |
| David J. Croyle | Chief Medical Officer | 1,550,000 |
| Jeffrey Appleman | Chief Financial Officer | – |
| Gerald Dial | Director | 12,000 |
| Liberty Smith Duke | Director | 1,512 |
| Mark Meller | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Feb 6, 2025
- Offer price
- $4.00
- Securities offered
- 1,280,000
- Gross proceeds
- $5.12M
- Exchange
- Nasdaq
- First trading day
- Feb 5, 2025
- First-day close
- $4.10+2.5%
- Lock-up ends (est.)
- Aug 4, 2025
“We are offering 1,280,000 shares of our common stock, par value $0.001 per share (“common stock”), at an initial public offering price of $4.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of the date of this report, we have 20 employees, of which 18 are full-time employees, and 2 are part-time or contractual/seasonal employees engaged on a seasonal and as-needed basis.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 16, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jul 2, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 10, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Feb 6, 2025 | IPO | Initial public offering priced (424B4 prospectus) |
| Feb 4, 2025 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?